# A Study to Evaluate the Safety of HS-10506 in Chinese Patients With Insomnia Disorder

> **NCT07677384** · PHASE3 · NOT_YET_RECRUITING · sponsor: **Jiangsu Hansoh Pharmaceutical Co., Ltd.** · enrollment: 600 (estimated)

## Conditions studied

- Insomnia Disorder

## Interventions

- **DRUG:** HS-10506

## Key facts

- **NCT ID:** NCT07677384
- **Lead sponsor:** Jiangsu Hansoh Pharmaceutical Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-06-12
- **Primary completion:** 2029-06-30
- **Final completion:** 2029-06-30
- **Target enrollment:** 600 (ESTIMATED)
- **Last updated:** 2026-06-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07677384

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07677384, "A Study to Evaluate the Safety of HS-10506 in Chinese Patients With Insomnia Disorder". Retrieved via MORVS 2026-10-21 from https://api.morvs.ai/clinical/NCT07677384. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*